Cleanspace Holdings Ltd. · ASX:CSX
Cleanspace — Shareholder Meeting (November 2025)
12 slides from Cleanspace's shareholder meeting presentation, Nov 28, 2025
Slide 1: FY25 AGM CEO Presentation
CleanSpace Holdings Limited (ASX: CSX) FY25 AGM CEO PRESENTATION Presented by Gabrielle O’Carroll 28 NOVEMBER 2025 1 CleanSpace Holdings Limited | FY25 AGM Presentation | November 2025
Slide 2: Important Notice & Disclaimer
IMPORTANT NOTICE & DISCLAIMER ACCEPTANCE FUTURE PERFORMANCE AND FORWARD-LOOKING STATEMENTS This presentation has been prepared by CleanSpace Holdings Limited (ACN 150 214 636) (CleanSpace). This presentation may contain forward-looking statements with respect to the operations and businesses of the
Slide 3: Our Vision and Our Mission
Our Vision To redefine respiratory protection world-wide by empowering every worker in high-risk environments to breath freely, safely, and confidently – anytime, anywhere. Our Mission CleanSpace is committed to continuous innovation and the development of respirators that offer superior quality, ar
Slide 4: FY25 - Another Year of Strong Momentum
FY25 - ANOTHER YEAR OF STRONG MOMENTUM North America +45% Enhanced Sales & Marketing Capability +26% APAC & ROW +36% Europe +18% • Sales Capability - strengthened global sales capabilities by Revenue $19.8M recruiting industry experts in priority markets Regional Revenue (v PCP); 3 consecutive years
Slide 5: FY25 Regional Sales Trends
Consumables FY25 REGIONAL SALES TRENDS 20% 4% Respirators Masks Filters Accessories 53% 23% FY25 Revenue by Region Europe - most established market - 18% revenue growth led by Western Europe (+19%), UK (+27%) and the Nordics (+17%) $3.0M - Reflects ongoing end user market demand for our solutions -
Slide 6: CleanSpace Achieved FY25 Objectives
CleanSpace ACHIEVED FY25 OBJECTIVES FY25 Objective FY25 Delivery Achieved 26% Revenue growth 25 – 30% Revenue growth Gross margin of 75% (+3%) Positive EBITDA achieved H2FY25 and for FY25 (adj. for $0.7M one off costs) EBITDA & Cashflow breakeven or better Achieved positive Cashflow in H2FY25 Strong
Slide 7: FY26 Strategy
FY26 STRATEGY Focus on industrial sectors – Where there is strong awareness of respiratory risks and established compliance requirements, and where respiratory protection is integral to duty-of-care. Key sectors include mining, quarries, welding, and oil & gas. Focus on high-potential geographic reg
Slide 8: Operating Update: FY26 October YTD (4mths)
OPERATING UPDATE: FY26 OCTOBER YTD (4mths) Sales revenue YTD +13% vs PCP. Reflecting the seasonality of the business, expectations are for 2H revenue to be stronger than 1H revenue. Performance by region for FY26 October YTD is: Region Comments • Solid performance with growth driven by France and th
Slide 9: Strategic Response to Evolving Market Conditions
STRATEGIC RESPONSE TO EVOLVING MARKET CONDITIONS Market Dynamics How are we responding Challenges in end user markets Sales and marketing framework Macro-economic environment creating Focus on pipeline development, caution in end user markets; distributors distribution network expansion, and are rep
Slide 10: Unique & Leading Innovations
UNIQUE & LEADING INNOVATIONS The future of respiratory safety – SMART monitoring for users and organisations. CleanSpace SMART App and CleanSpace Insights Reports bring a new level of intelligence to respiratory protection. Together, they provide a powerful, data- driven approach to improving workpl
Slide 11: FY26 Objectives
FY26 OBJECTIVES Deliver strong financial performance • H1 revenue growth anticipated to align with YTD trends, while we continue to target >20% growth for the full year, driving stronger operating leverage • Gross margin in the mid-70% range • Positive Operating EBITDA and Cash Flow • Continuing cos
Slide 12: Thank You!
THANK YOU! 12 CleanSpace Holdings Limited | FY25 AGM Presentation | November 2025
CleanSpace Holdings — Shareholder Meeting (November 2025) on 6ix